Back
Eagle Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
EGRX
Sponsored
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Sell
20
EGRX
Eagle Pharmaceuticals
Last Price:
0.80
Seasonality Move:
-1.64%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret LoopholeEagle Pharmaceuticals Price Quote
$0.80
+0.30 (+60%)
(Updated: November 5, 2024 at 5:55 PM ET)
Eagle Pharmaceuticals Key Stats
Sell
20
Eagle Pharmaceuticals (EGRX)
is a Sell
Day range:
$0.45 - $0.75
52-week range:
$0.00 - $14.40
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
26.2K
Avg. volume:
314K
1-year change:
-96.53%
Market cap:
$6.5M
Revenue:
$0
EPS:
$0.91
How Much Does Eagle Pharmaceuticals Make?
-
How Much Are Eagle Pharmaceuticals's Sales Annually?
EGRX Revenues are $0 -
How Much Profit Does Eagle Pharmaceuticals's Make A Year?
EGRX net income is $0
Is Eagle Pharmaceuticals Growing As A Company?
-
What Is Eagle Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.13% -
What Is Eagle Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Eagle Pharmaceuticals Stock Price Performance
-
Did Eagle Pharmaceuticals Stock Go Up Last Month?
Eagle Pharmaceuticals share price went down by -44.44% last month -
Did EGRX's Share Price Rise Over The Last Year?
EGRX share price fell by -96.53% over the past 1 year
What Is Eagle Pharmaceuticals 52-Week High & Low?
-
What Is Eagle Pharmaceuticals’s 52-Week High Share Price?
Eagle Pharmaceuticals has traded as high as $14.40 over the past 52 weeks -
What Is Eagle Pharmaceuticals’s 52-Week Low Share Price?
Eagle Pharmaceuticals has traded as low as $0.00 over the past 52 weeks
Eagle Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Eagle Pharmaceuticals?
-
How Much Debt Does Eagle Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Eagle Pharmaceuticals Have?
Cash and short term investments quarterly total is $15.4M -
What Is Eagle Pharmaceuticals’s Book Value Per Share?
Book value per share is 19.25
Is Eagle Pharmaceuticals Cash Flow Positive?
-
What Is EGRX Cash Flow From Operations?
Cash flow from operations (TTM) is -$9.3M -
What Is Eagle Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $11.9M -
What Is Eagle Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$23.8M
Eagle Pharmaceuticals Return On Invested Capital
Data Unavailable
Eagle Pharmaceuticals Earnings Date & Stock Price
-
What Is Eagle Pharmaceuticals's Stock Price Today?
A single share of EGRX can be purchased today for 0.50 -
What Is Eagle Pharmaceuticals’s Stock Symbol?
Eagle Pharmaceuticals trades on the otcm under the ticker symbol: EGRX -
When Is Eagle Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Eagle Pharmaceuticals is scheduled on November 6, 2024 -
When Is EGRX's next ex-dividend date?
Eagle Pharmaceuticals's next ex-dividend date is November 6, 2024 -
How To Buy Eagle Pharmaceuticals Stock?
You can buy Eagle Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Eagle Pharmaceuticals Competitors
-
Who Are Eagle Pharmaceuticals's Competitors?
Below is a list of companies who compete with Eagle Pharmaceuticals or are related in some way:
Eagle Pharmaceuticals Dividend Yield
-
What Is EGRX Dividend Yield?
Eagle Pharmaceuticals’s dividend yield currently is 0% -
What Is Eagle Pharmaceuticals’s Payout Ratio?
Eagle Pharmaceuticals’s payout ratio is 0% -
When Did Eagle Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is November 6, 2024 -
What Is Eagle Pharmaceuticals’s Dividend Per Share?
Eagle Pharmaceuticals pays a dividend of $0.00 per share
Eagle Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 3.51% |
Revenue: | -12.8% | 8.9% |
Analyst Recommendations
Buy Recommendations: | 1 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 17.00 |
Upside from Last Price: | 3300% |